<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0003623'>Neonatal-onset</z:hpo> multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>; also known as <z:hpo ids='HP_0011010'>chronic</z:hpo> infantile neurologic, cutaneous, articular [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>] syndrome) is characterized by <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001287'>meningitis</z:hpo>, <z:hpo ids='HP_0000554'>uveitis</z:hpo>, <z:mp ids='MP_0004740'>sensorineural hearing loss</z:mp>, urticarial <z:hpo ids='HP_0000988'>skin rash</z:hpo>, and a characteristic deforming <z:hpo ids='HP_0003040'>arthropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether patients with this disorder have mutations in CIAS1, the gene which causes <z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> and <z:e sem="disease" ids="C1610600" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">familial cold autoinflammatory syndrome</z:e>, two dominantly inherited disorders with some similarities to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>/<z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Genomic DNA from 13 patients with classic manifestations of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>/<z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> and their available parents was screened for CIAS1 mutations by automated DNA sequencing </plain></SENT>
<SENT sid="3" pm="."><plain>Cytokine <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) levels were assessed by real-time polymerase chain reaction on peripheral blood leukocyte <z:chebi fb="2" ids="33699">mRNA</z:chebi>, and serum cytokine levels were assayed by enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="4" pm="."><plain>Protein expression was assessed by Western blotting of lysates from plastic-adherent peripheral blood mononuclear cells </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In 6 of the 13 patients, we found 6 heterozygous missense substitutions in CIAS1 </plain></SENT>
<SENT sid="6" pm="."><plain>Five of the 6 mutations are novel </plain></SENT>
<SENT sid="7" pm="."><plain>None of these sequence changes was observed in a panel of &gt;900 chromosomes from healthy controls </plain></SENT>
<SENT sid="8" pm="."><plain>Two distinct nucleotide changes in a single codon in unrelated patients resulted in the same amino acid change </plain></SENT>
<SENT sid="9" pm="."><plain>In 4 mutation-positive children whose parental DNA was available, no mutation was found in the parental DNA, supporting the conclusion that the mutations arose de novo </plain></SENT>
<SENT sid="10" pm="."><plain>Consistent with the recently discovered role of CIAS1 in the regulation of interleukin-1 (IL-1), we found evidence of increased IL-1beta, as well as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor, IL-3, IL-5, and IL-6, but not transforming growth factor beta, in a mutation-positive patient compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Our data increase the total number of known germline mutations in CIAS1 to 20, causing a spectrum of diseases ranging from <z:e sem="disease" ids="C1610600" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">familial cold autoinflammatory syndrome</z:e> to <z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>/<z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Mutations in CIAS1 were only found in approximately 50% of the cases identified clinically as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>/<z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e>, which raises the possibility of <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>IL-1 regulation by CIAS1 suggests that IL-1 receptor blockade may constitute a rational approach to the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e>/<z:e sem="disease" ids="C0409818" disease_type="Disease or Syndrome" abbrv="CINCA">CINCA syndrome</z:e> </plain></SENT>
</text></document>